Physician profile
Keyana Mariah Kelley
NPI 1821653791
$2,604.24
in general payments reported to CMS, 2019-2025
14 companies · $434 in 2025
The $434 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.31 · 2020: $71.88 · 2021: $355 · 2022: $164 · 2023: $1,492 · 2024: $75.42 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,963 · Entertainment: $38.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,962.86 |
| Entertainment | $38.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $557.47 | 2020-2025 | Precision7, Hydrus Microstent, Total30 |
| Coopervision INC. | $488.54 | 2020-2025 | Myday Contact Lens, Misight Contact Lens |
| Lumenis Be INC | $477.72 | 2023 | M22 |
| Topcon Healthcare, INC. | $227.58 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $157.62 | 2025 | Xdemvy |
| Biotissue Holdings INC. | $142.79 | 2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $136.31 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $109.61 | 2021 | |
| Optos, INC. | $84.52 | 2022-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Lombart Brothers, INC. | $71.70 | 2025 | Opd-III |
| Abb Con-Cise Optical Group LLC | $65.76 | 2022 | |
| Allergan, INC. | $47.68 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $22.42 | 2022 | |
| Dompe US, INC. | $14.52 | 2023 | Oxervate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keyana Kelley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.